Document is current
Any future updates will be listed below
-
Authors
Boussina, Aaron
Langouche, Lennart
Obirieze, Augustine C.
Sinha, Mridu
Mack, Hannah
Leineweber, William
Aralar, April
Pride, David T.
Coleman, Todd P.
Fraley, Stephanie I.
-
Funding
Funding for this research was provided by:
U.S. National Library of Medicine (2T15LM011271-11)
NIAID (R01AI134982)
- License Information
-
More Information
Article History
Received: 15 May 2023
Accepted: 14 March 2024
First Online: 10 May 2024
Declarations
:
: Not applicable.
: Not applicable.
: S.I.F. is a co-founder, director, and scientific advisor of MelioLabs, Inc. and has an equity interest in the company. T.P.C. is a director of MelioLabs, Inc. and has an equity interest in the company. M.S. is a co-founder and CEO of MelioLabs and has equity interest in the company. D.T.P. is an advisor of MelioLabs and has equity interest in the company. NIAID award number R01AI134982 has been identified for conflict-of-interest management based on the overall scope of the project and its potential benefit to MelioLabs, Inc.; however, the research findings included in this particular publication may not necessarily relate to the interests of MelioLabs, Inc. The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict-of-interest policies. The remaining authors have no conflict-of-interest to declare.
